Inotek Appoints Paul G. Howes as President and CEO

(PR-inside.com) - Inotek Pharmaceuticals Corporation Jeffrey T. Walsh, 978-201-9129 EVP and Chief Business Officer or MacDougall Biomedical Communications Sarah Cavanaugh, 781-235-3060 Inotek Pharmaceuticals Corporation announced today that it has hired Paul G. Howes as President, CEO and Director. Mr. Howes brings more than twenty years of senior level pharmaceutical experience to Inotek, most recently serving as President of the Americas Region for Bausch and Lomb where he had full commercial responsibility for the Vision Care, Surgical and Pharmaceuticals segments in the United States, Canada, Latin America and South America. Prior to Bausch and Lomb, Mr. Howes worked at Merck and Co. ..

More...